Relationship between symptom impairment and treatment outcome in children and adolescents with attention-deficit/hyperactivity disorder: a physician perspective

被引:5
|
作者
Setyawan, Juliana [1 ]
Fridman, Moshe [2 ]
Hodgkins, Paul [1 ]
Quintero, Javier [3 ]
Erder, M. Haim [1 ]
Katic, Bozena J. [1 ]
Harpin, Valerie [4 ]
机构
[1] Shire, 725 Chesterbrook Blvd, Wayne, PA 19087 USA
[2] AMF Consulting Inc, Los Angeles, CA USA
[3] Hosp Univ Infanta Leonor, Madrid, Spain
[4] Ryegate Childrens Ctr, Sheffield, S Yorkshire, England
关键词
ADHD; Children and adolescents; Treatment outcomes; Treatment satisfaction; Symptom impairment; Comorbidities;
D O I
10.1007/s12402-014-0143-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We evaluated the association between those symptoms/behaviours of attention-deficit/hyperactivity disorder (ADHD) that were present at diagnosis and outcomes of treatment in children and adolescents in six European countries. Physicians abstracted clinical records from patients (6-17 years) diagnosed with ADHD between 2004 and 2007 and treated for >= 2 years. Physicians scored the severity of impairment for core ADHD symptoms and additional (non-core) ADHD symptoms/behaviours at diagnosis and estimated treatment adherence (defined as an estimated >80 % adherence on weekdays and >50 % adherence on weekends). Treatment modalities included pharmacological treatment, behavioural therapy, or both. Pharmacological treatment was further subclassified by medication class. The outcome, optimal treatment success (OTS), was defined as complete symptom control with high satisfaction with treatment. Multivariate logistic regression modelling examined the relationship between OTS and symptom impairment. Of 730 patients, 200 (27 %) achieved OTS. These patients were more likely to demonstrate lower impairment in non-core ADHD symptoms/behaviours and have fewer pre-existing comorbidities. They were also more likely to be adherent and engaged with treatment, with an explicit treatment goal to improve inattention/school performance. Neither core symptoms' severity nor treatment types were associated with OTS. OTS rates were low, with patients having less impairment of non-core ADHD symptoms/behaviours and fewer comorbidities more likely to achieve OTS. Potentially modifiable factors affecting OTS were as follows: treatment adherence, treatment engagement, and a treatment goal to improve inattention/school performance. These data suggest that there may be opportunities to optimize current treatment use, and develop new treatment strategies to improve core and non-core ADHD symptoms/behaviours.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 50 条
  • [41] Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder
    Pliszka, Steven
    Bernet, William
    Bukstein, Oscar
    Walter, Heather J.
    Arnold, Valerie
    Beitchman, Joseph
    Benson, R. Scott
    Chrisman, Allan
    Farchione, Tiffany
    Hamilton, John
    Keable, Helene
    Kinlan, Joan
    McClellan, Jon
    Rue, David
    Schoettle, Ulrich
    Shaw, Jon A.
    Stock, Saundra
    Ptakowski, Kristin Kroeger
    Medicus, Jennifer
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2007, 46 (07): : 894 - 921
  • [42] Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
    Connor, Daniel F.
    Arnsten, Amy F. T.
    Pearson, Geraldine S.
    Greco, Gabriella F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1601 - 1610
  • [43] Prevalence of bipolar disorder in children and adolescents with attention-deficit hyperactivity disorder
    Hassan, Amani
    Agha, Sharifah Shameem
    Langley, Kate
    Thapar, Anita
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 198 (03) : 195 - 198
  • [44] Persistence of Stimulants in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Palli, Swetha R.
    Kamble, Pravin S.
    Chen, Hua
    Aparasu, Rajender R.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (02) : 139 - 148
  • [45] Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder
    Poulton, Alison
    Kwok, Samson
    Nanan, Ralph
    PEDIATRICS, 2008, 122 (04) : 910 - 910
  • [46] Loneliness in Children and Adolescents With and Without Attention-Deficit/Hyperactivity Disorder
    Houghton, Stephen
    Roost, Eileen
    Carroll, Annemaree
    Brandtman, Mark
    JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 2015, 37 (01) : 27 - 37
  • [47] The economic impact of Attention-Deficit/Hyperactivity disorder in children and adolescents
    Pelham, William E.
    Foster, E. Michael
    Robb, Jessica A.
    JOURNAL OF PEDIATRIC PSYCHOLOGY, 2007, 32 (06) : 711 - 727
  • [48] Attention-deficit hyperactivity disorder - bipolar comorbidity in children and adolescents
    Masi, Gabriele
    Perugi, Giulio
    Toni, Cristina
    Millepiedi, Stefania
    Mucci, Maria
    Bertini, Nicoletta
    Pfanner, Chiara
    BIPOLAR DISORDERS, 2006, 8 (04) : 373 - 381
  • [49] Sleep quality in children and adolescents with attention-deficit and hyperactivity disorder
    Miniksar, Dilsad Yildiz
    Ozdemir, Mikail
    ARCHIVES DE PEDIATRIE, 2021, 28 (08): : 668 - 676
  • [50] Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    Garnock-Jones, Karly P.
    Keating, Gillian M.
    CNS DRUGS, 2010, 24 (01) : 85 - 88